Susan Majka
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung | 24 | 2024 | 3593 | 2.700 |
Why?
| Wnt Signaling Pathway | 6 | 2023 | 147 | 2.050 |
Why?
| Stem Cells | 14 | 2023 | 546 | 1.420 |
Why?
| Hypertension, Pulmonary | 17 | 2022 | 1737 | 1.360 |
Why?
| Neovascularization, Physiologic | 4 | 2020 | 173 | 1.260 |
Why?
| Cell Separation | 5 | 2020 | 292 | 1.200 |
Why?
| Adipocytes | 7 | 2022 | 188 | 1.070 |
Why?
| Cell Lineage | 10 | 2020 | 310 | 1.060 |
Why?
| Cell Differentiation | 18 | 2021 | 1699 | 1.020 |
Why?
| Adipose Tissue | 9 | 2022 | 539 | 0.990 |
Why?
| Microvessels | 2 | 2017 | 68 | 0.910 |
Why?
| Stem Cell Niche | 3 | 2020 | 42 | 0.890 |
Why?
| Lung Injury | 4 | 2019 | 198 | 0.860 |
Why?
| Mice | 40 | 2023 | 14936 | 0.840 |
Why?
| Pulmonary Fibrosis | 4 | 2017 | 323 | 0.810 |
Why?
| beta Catenin | 3 | 2020 | 220 | 0.810 |
Why?
| Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 928 | 0.810 |
Why?
| Endothelium, Vascular | 5 | 2020 | 848 | 0.770 |
Why?
| Fibrosis | 4 | 2019 | 454 | 0.760 |
Why?
| Neovascularization, Pathologic | 2 | 2020 | 283 | 0.750 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2023 | 359 | 0.740 |
Why?
| Animals | 53 | 2023 | 31839 | 0.720 |
Why?
| Endothelial Progenitor Cells | 1 | 2020 | 18 | 0.720 |
Why?
| Airway Remodeling | 1 | 2020 | 57 | 0.700 |
Why?
| Myeloid Cells | 4 | 2019 | 128 | 0.690 |
Why?
| Wnt Proteins | 1 | 2020 | 135 | 0.660 |
Why?
| Immunophenotyping | 1 | 2020 | 277 | 0.640 |
Why?
| Polycystic Kidney Diseases | 1 | 2019 | 55 | 0.640 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 350 | 0.640 |
Why?
| Bone Marrow Cells | 7 | 2021 | 267 | 0.630 |
Why?
| Cells, Cultured | 15 | 2020 | 3897 | 0.620 |
Why?
| Pericytes | 2 | 2017 | 24 | 0.620 |
Why?
| Bone Morphogenetic Protein Receptors, Type II | 4 | 2017 | 48 | 0.610 |
Why?
| PPAR gamma | 5 | 2022 | 183 | 0.590 |
Why?
| Leukocyte Common Antigens | 5 | 2011 | 76 | 0.560 |
Why?
| Pulmonary Artery | 11 | 2022 | 1028 | 0.540 |
Why?
| Flow Cytometry | 7 | 2018 | 1087 | 0.540 |
Why?
| Endothelial Cells | 5 | 2022 | 685 | 0.540 |
Why?
| Myocytes, Smooth Muscle | 7 | 2020 | 236 | 0.510 |
Why?
| Cell- and Tissue-Based Therapy | 2 | 2016 | 56 | 0.490 |
Why?
| Adipocytes, White | 2 | 2015 | 17 | 0.490 |
Why?
| ATP-Binding Cassette Transporters | 2 | 2014 | 123 | 0.470 |
Why?
| Mesoderm | 4 | 2010 | 138 | 0.460 |
Why?
| Pluripotent Stem Cells | 1 | 2014 | 63 | 0.440 |
Why?
| Cell Proliferation | 8 | 2018 | 2199 | 0.420 |
Why?
| Lung Diseases | 4 | 2016 | 703 | 0.400 |
Why?
| Induced Pluripotent Stem Cells | 2 | 2011 | 182 | 0.400 |
Why?
| Bleomycin | 3 | 2019 | 228 | 0.390 |
Why?
| Neoplasm Proteins | 1 | 2014 | 385 | 0.380 |
Why?
| Benzimidazoles | 2 | 2011 | 138 | 0.370 |
Why?
| Mice, Transgenic | 12 | 2022 | 1953 | 0.370 |
Why?
| Calcification, Physiologic | 1 | 2011 | 34 | 0.370 |
Why?
| Pulmonary Circulation | 3 | 2009 | 408 | 0.360 |
Why?
| Mice, Inbred C57BL | 17 | 2022 | 4719 | 0.360 |
Why?
| Intra-Abdominal Fat | 1 | 2011 | 77 | 0.360 |
Why?
| Osteoblasts | 1 | 2011 | 106 | 0.350 |
Why?
| Hypoxia | 9 | 2021 | 960 | 0.350 |
Why?
| Pulmonary Emphysema | 3 | 2022 | 280 | 0.340 |
Why?
| Fibroblast Growth Factor 10 | 3 | 2019 | 24 | 0.340 |
Why?
| Familial Primary Pulmonary Hypertension | 5 | 2014 | 190 | 0.340 |
Why?
| Osteogenesis | 1 | 2011 | 183 | 0.320 |
Why?
| Regeneration | 5 | 2019 | 160 | 0.310 |
Why?
| Phenotype | 7 | 2020 | 2817 | 0.310 |
Why?
| Respiratory System | 1 | 2009 | 138 | 0.300 |
Why?
| Humans | 38 | 2024 | 114937 | 0.300 |
Why?
| Mice, Knockout | 7 | 2021 | 2587 | 0.290 |
Why?
| Mutation | 2 | 2021 | 3354 | 0.270 |
Why?
| Immunomodulation | 2 | 2021 | 84 | 0.270 |
Why?
| Myofibroblasts | 2 | 2019 | 116 | 0.260 |
Why?
| Apoptosis | 4 | 2013 | 2371 | 0.260 |
Why?
| Vasoconstriction | 2 | 2017 | 186 | 0.250 |
Why?
| Matrix Metalloproteinase 2 | 2 | 2002 | 57 | 0.250 |
Why?
| Superoxide Dismutase | 3 | 2014 | 305 | 0.250 |
Why?
| Respiratory Mucosa | 2 | 2019 | 251 | 0.240 |
Why?
| Vascular Remodeling | 3 | 2022 | 153 | 0.240 |
Why?
| Pneumoconiosis | 1 | 2024 | 12 | 0.230 |
Why?
| Coal Mining | 1 | 2024 | 11 | 0.230 |
Why?
| Cell Line | 3 | 2020 | 2640 | 0.230 |
Why?
| Disease Models, Animal | 8 | 2022 | 3549 | 0.220 |
Why?
| T-Lymphocytes | 1 | 2011 | 1749 | 0.220 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2023 | 1893 | 0.220 |
Why?
| Muscle, Smooth, Vascular | 4 | 2015 | 417 | 0.210 |
Why?
| Granuloma, Respiratory Tract | 1 | 2002 | 12 | 0.210 |
Why?
| Cryptococcus neoformans | 1 | 2002 | 18 | 0.200 |
Why?
| Cryptococcosis | 1 | 2002 | 23 | 0.200 |
Why?
| Epithelial Cells | 4 | 2020 | 958 | 0.200 |
Why?
| Leptin | 2 | 2022 | 211 | 0.200 |
Why?
| Retinal Neovascularization | 1 | 2002 | 20 | 0.200 |
Why?
| Hemopexin | 1 | 2021 | 13 | 0.190 |
Why?
| Cell Hypoxia | 2 | 2020 | 220 | 0.190 |
Why?
| Fibroblasts | 3 | 2018 | 839 | 0.190 |
Why?
| Potassium Channels, Tandem Pore Domain | 1 | 2021 | 12 | 0.190 |
Why?
| Urokinase-Type Plasminogen Activator | 2 | 1999 | 28 | 0.190 |
Why?
| Male | 19 | 2020 | 55663 | 0.190 |
Why?
| Cigarette Smoking | 1 | 2022 | 74 | 0.190 |
Why?
| Occupational Exposure | 1 | 2024 | 256 | 0.190 |
Why?
| Matrix Metalloproteinases | 1 | 2002 | 89 | 0.190 |
Why?
| Tamoxifen | 2 | 2019 | 192 | 0.180 |
Why?
| Calgranulin B | 1 | 2020 | 7 | 0.180 |
Why?
| Biomarkers | 5 | 2021 | 3418 | 0.180 |
Why?
| Acute Lung Injury | 2 | 2017 | 300 | 0.180 |
Why?
| Myocardium | 4 | 2019 | 911 | 0.180 |
Why?
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2020 | 11 | 0.180 |
Why?
| Muscle, Skeletal | 3 | 2009 | 1472 | 0.180 |
Why?
| Glutathione Peroxidase | 1 | 2020 | 41 | 0.180 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2011 | 799 | 0.170 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2019 | 26 | 0.170 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 21 | 0.170 |
Why?
| Vascular System Injuries | 1 | 2020 | 64 | 0.170 |
Why?
| RNA Stability | 1 | 2020 | 90 | 0.160 |
Why?
| Cell Culture Techniques | 2 | 2020 | 344 | 0.160 |
Why?
| Smoke | 1 | 2020 | 127 | 0.160 |
Why?
| Receptor, Serotonin, 5-HT2B | 1 | 2018 | 2 | 0.160 |
Why?
| Female | 16 | 2022 | 59581 | 0.160 |
Why?
| Myeloid Progenitor Cells | 1 | 2018 | 15 | 0.160 |
Why?
| Hematopoietic Stem Cells | 5 | 2022 | 345 | 0.160 |
Why?
| Kidney Tubules, Proximal | 1 | 2019 | 113 | 0.160 |
Why?
| Laryngostenosis | 1 | 2018 | 20 | 0.160 |
Why?
| Cyclic AMP Response Element-Binding Protein | 2 | 2011 | 127 | 0.160 |
Why?
| Anemia, Sickle Cell | 1 | 2021 | 216 | 0.150 |
Why?
| Cicatrix | 1 | 2018 | 50 | 0.150 |
Why?
| Cadherins | 1 | 2019 | 176 | 0.150 |
Why?
| Alveolar Epithelial Cells | 1 | 2019 | 96 | 0.150 |
Why?
| Membrane Proteins | 2 | 2022 | 1022 | 0.150 |
Why?
| Interleukin-17 | 1 | 2018 | 104 | 0.150 |
Why?
| Benzaldehydes | 1 | 2017 | 8 | 0.150 |
Why?
| Ventricular Remodeling | 1 | 2019 | 227 | 0.150 |
Why?
| Niacinamide | 1 | 2017 | 64 | 0.150 |
Why?
| Inflammation Mediators | 1 | 2020 | 476 | 0.150 |
Why?
| Nerve Tissue Proteins | 1 | 2021 | 529 | 0.140 |
Why?
| Integrin beta1 | 1 | 2017 | 16 | 0.140 |
Why?
| Heart | 2 | 1999 | 609 | 0.140 |
Why?
| Signal Transduction | 8 | 2019 | 4525 | 0.140 |
Why?
| Thiazolidinediones | 2 | 2009 | 142 | 0.140 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2002 | 1134 | 0.140 |
Why?
| Protein Stability | 1 | 2017 | 157 | 0.140 |
Why?
| MicroRNAs | 1 | 2022 | 601 | 0.140 |
Why?
| Hemoglobins | 2 | 2021 | 314 | 0.130 |
Why?
| Hypoxia-Inducible Factor 1 | 1 | 2015 | 68 | 0.120 |
Why?
| Trans-Activators | 1 | 1997 | 368 | 0.120 |
Why?
| Gene Expression Regulation | 5 | 2022 | 2324 | 0.120 |
Why?
| Adult | 5 | 2020 | 30608 | 0.120 |
Why?
| Promoter Regions, Genetic | 3 | 2015 | 1133 | 0.120 |
Why?
| Inflammation | 3 | 2022 | 2485 | 0.120 |
Why?
| Repressor Proteins | 1 | 1997 | 368 | 0.120 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 249 | 0.120 |
Why?
| Insulin | 2 | 2022 | 2079 | 0.120 |
Why?
| Macrophages | 3 | 2022 | 1266 | 0.120 |
Why?
| Proto-Oncogene Proteins | 1 | 1997 | 611 | 0.110 |
Why?
| Vascular Stiffness | 1 | 2018 | 408 | 0.110 |
Why?
| Genetic Predisposition to Disease | 3 | 2021 | 2102 | 0.110 |
Why?
| Aging | 1 | 2023 | 1621 | 0.110 |
Why?
| Animals, Newborn | 2 | 2009 | 777 | 0.110 |
Why?
| Cell Fusion | 2 | 2015 | 50 | 0.110 |
Why?
| Transforming Growth Factor beta1 | 1 | 2014 | 153 | 0.110 |
Why?
| Leukocytes, Mononuclear | 2 | 2022 | 496 | 0.110 |
Why?
| Polymerase Chain Reaction | 2 | 2018 | 995 | 0.110 |
Why?
| Hydrogen Peroxide | 2 | 2012 | 287 | 0.110 |
Why?
| Models, Biological | 4 | 2021 | 1630 | 0.110 |
Why?
| Fatty Acid-Binding Proteins | 2 | 2023 | 61 | 0.110 |
Why?
| Myocardial Infarction | 1 | 2019 | 929 | 0.100 |
Why?
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.100 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 929 | 0.100 |
Why?
| ADAM Proteins | 2 | 2022 | 58 | 0.100 |
Why?
| Early Growth Response Protein 1 | 2 | 2010 | 24 | 0.100 |
Why?
| Cytological Techniques | 1 | 2011 | 23 | 0.100 |
Why?
| Receptors, Immunologic | 1 | 2013 | 201 | 0.100 |
Why?
| Mice, Nude | 2 | 2011 | 635 | 0.100 |
Why?
| Receptor, TIE-2 | 1 | 2011 | 12 | 0.100 |
Why?
| Ventricular Pressure | 1 | 2011 | 37 | 0.100 |
Why?
| Regenerative Medicine | 1 | 2011 | 41 | 0.090 |
Why?
| Integrin-Binding Sialoprotein | 1 | 2011 | 4 | 0.090 |
Why?
| Osteocalcin | 1 | 2011 | 34 | 0.090 |
Why?
| Diet, High-Fat | 1 | 2012 | 225 | 0.090 |
Why?
| Mice, Inbred ICR | 1 | 2011 | 109 | 0.090 |
Why?
| DNA-Binding Proteins | 1 | 1997 | 1317 | 0.090 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 744 | 0.090 |
Why?
| Adipocytes, Brown | 1 | 2010 | 6 | 0.090 |
Why?
| World Health Organization | 1 | 2011 | 103 | 0.090 |
Why?
| Cytogenetic Analysis | 1 | 2010 | 29 | 0.090 |
Why?
| Bone Morphogenetic Proteins | 1 | 2011 | 132 | 0.090 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 330 | 0.090 |
Why?
| Gene Expression Profiling | 2 | 2021 | 1523 | 0.090 |
Why?
| Lymphoid Progenitor Cells | 1 | 2009 | 11 | 0.090 |
Why?
| Extracellular Space | 1 | 2010 | 117 | 0.090 |
Why?
| RNA, Messenger | 4 | 2009 | 2559 | 0.080 |
Why?
| Bronchoconstriction | 1 | 2009 | 27 | 0.080 |
Why?
| Vascular Diseases | 1 | 2012 | 230 | 0.080 |
Why?
| Syndecan-4 | 1 | 2009 | 7 | 0.080 |
Why?
| Ventricular Function, Right | 1 | 2011 | 252 | 0.080 |
Why?
| Case-Control Studies | 4 | 2021 | 3008 | 0.080 |
Why?
| Genotype | 2 | 2011 | 1775 | 0.080 |
Why?
| AC133 Antigen | 1 | 2008 | 19 | 0.080 |
Why?
| Satellite Cells, Skeletal Muscle | 1 | 2009 | 24 | 0.080 |
Why?
| Giant Cells | 1 | 2008 | 21 | 0.080 |
Why?
| Tissue Scaffolds | 1 | 2011 | 179 | 0.080 |
Why?
| Neprilysin | 1 | 2009 | 47 | 0.080 |
Why?
| Middle Aged | 5 | 2020 | 26806 | 0.080 |
Why?
| Muscle, Smooth | 1 | 2009 | 147 | 0.080 |
Why?
| Hyperoxia | 1 | 2009 | 100 | 0.080 |
Why?
| Thrombosis | 1 | 2011 | 297 | 0.080 |
Why?
| Infant, Newborn, Diseases | 1 | 2009 | 104 | 0.070 |
Why?
| Vasodilator Agents | 1 | 2009 | 305 | 0.070 |
Why?
| Receptor for Advanced Glycation End Products | 2 | 2020 | 29 | 0.070 |
Why?
| Activating Transcription Factor 1 | 1 | 2006 | 9 | 0.070 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 15 | 0.070 |
Why?
| Glycoproteins | 1 | 2008 | 305 | 0.070 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 32 | 0.070 |
Why?
| Immunohistochemistry | 2 | 2018 | 1635 | 0.070 |
Why?
| Reactive Oxygen Species | 1 | 2009 | 536 | 0.070 |
Why?
| RNA, Small Interfering | 4 | 2011 | 543 | 0.070 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 499 | 0.070 |
Why?
| Cell Nucleus | 1 | 2009 | 554 | 0.070 |
Why?
| Antigens, CD | 1 | 2008 | 443 | 0.070 |
Why?
| Bone Marrow Transplantation | 3 | 2019 | 241 | 0.070 |
Why?
| Cytokines | 3 | 2021 | 1843 | 0.070 |
Why?
| Aged | 3 | 2020 | 19122 | 0.060 |
Why?
| Age Factors | 2 | 2010 | 2891 | 0.060 |
Why?
| Sex Factors | 1 | 2010 | 1721 | 0.060 |
Why?
| Young Adult | 1 | 2020 | 10478 | 0.060 |
Why?
| Pyrroles | 2 | 2018 | 183 | 0.060 |
Why?
| Adiponectin | 2 | 2022 | 213 | 0.060 |
Why?
| Silicates | 1 | 2024 | 11 | 0.060 |
Why?
| Coal | 1 | 2024 | 12 | 0.060 |
Why?
| Insulin Resistance | 1 | 2012 | 1072 | 0.060 |
Why?
| Indoles | 2 | 2018 | 306 | 0.060 |
Why?
| Sepsis | 1 | 2009 | 508 | 0.060 |
Why?
| Microscopy, Electron, Scanning | 1 | 2024 | 192 | 0.060 |
Why?
| Dust | 1 | 2024 | 84 | 0.050 |
Why?
| Blotting, Western | 3 | 2012 | 1151 | 0.050 |
Why?
| Muscle Cells | 1 | 2003 | 42 | 0.050 |
Why?
| Peptides | 1 | 2008 | 848 | 0.050 |
Why?
| Silicon Dioxide | 1 | 2024 | 88 | 0.050 |
Why?
| Guanine | 1 | 2003 | 76 | 0.050 |
Why?
| Hypertrophy, Right Ventricular | 2 | 2014 | 141 | 0.050 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 797 | 0.050 |
Why?
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2002 | 12 | 0.050 |
Why?
| X-Ray Microtomography | 1 | 2022 | 74 | 0.050 |
Why?
| Endothelium | 1 | 2003 | 112 | 0.050 |
Why?
| Diphtheria Toxin | 1 | 2022 | 52 | 0.050 |
Why?
| Ceramides | 1 | 2022 | 94 | 0.050 |
Why?
| ADAM17 Protein | 1 | 2002 | 31 | 0.050 |
Why?
| Metalloendopeptidases | 1 | 2002 | 55 | 0.050 |
Why?
| In Situ Nick-End Labeling | 1 | 2002 | 119 | 0.050 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2014 | 184 | 0.050 |
Why?
| Leukocyte Count | 1 | 2002 | 292 | 0.050 |
Why?
| Heme | 1 | 2021 | 52 | 0.050 |
Why?
| Quail | 2 | 1999 | 5 | 0.050 |
Why?
| Immunoenzyme Techniques | 1 | 2002 | 195 | 0.050 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2002 | 119 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 139 | 0.050 |
Why?
| Phosphoproteins | 2 | 2017 | 299 | 0.050 |
Why?
| Leukocytes | 1 | 2022 | 277 | 0.050 |
Why?
| Cell Division | 3 | 2009 | 759 | 0.050 |
Why?
| Wound Healing | 1 | 2003 | 258 | 0.040 |
Why?
| Hemolysis | 1 | 2021 | 146 | 0.040 |
Why?
| Hematopoiesis | 1 | 2001 | 172 | 0.040 |
Why?
| Enzyme Inhibitors | 1 | 2003 | 752 | 0.040 |
Why?
| Models, Animal | 1 | 2002 | 346 | 0.040 |
Why?
| Obesity | 1 | 2012 | 2514 | 0.040 |
Why?
| Rats | 3 | 2013 | 4963 | 0.040 |
Why?
| Vital Capacity | 1 | 2020 | 257 | 0.040 |
Why?
| Lymphocytes | 1 | 2021 | 333 | 0.040 |
Why?
| Benzodioxoles | 1 | 2020 | 84 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2021 | 316 | 0.040 |
Why?
| Epithelium | 1 | 2020 | 298 | 0.040 |
Why?
| Hepatocyte Growth Factor | 1 | 1999 | 33 | 0.040 |
Why?
| Arterioles | 1 | 2018 | 39 | 0.040 |
Why?
| Stem Cell Transplantation | 3 | 2006 | 149 | 0.040 |
Why?
| Infant, Newborn | 1 | 2009 | 5035 | 0.040 |
Why?
| Quinazolines | 1 | 2020 | 243 | 0.040 |
Why?
| Monocytes | 1 | 2021 | 504 | 0.040 |
Why?
| Enzyme Activation | 1 | 2020 | 790 | 0.040 |
Why?
| Biopsy, Needle | 1 | 2018 | 183 | 0.040 |
Why?
| Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 3 | 0.040 |
Why?
| Cell Adhesion | 1 | 2019 | 430 | 0.040 |
Why?
| Transfection | 2 | 2013 | 870 | 0.040 |
Why?
| Proto-Oncogene Proteins c-ets | 1 | 1997 | 51 | 0.040 |
Why?
| DNA Primers | 2 | 2009 | 514 | 0.040 |
Why?
| Rats, Sprague-Dawley | 2 | 2013 | 2211 | 0.040 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 81 | 0.040 |
Why?
| Drug Evaluation, Preclinical | 1 | 2017 | 165 | 0.040 |
Why?
| Blood Pressure | 2 | 2014 | 1537 | 0.040 |
Why?
| Reference Values | 1 | 2018 | 741 | 0.040 |
Why?
| Embryo, Nonmammalian | 1 | 1997 | 173 | 0.040 |
Why?
| Angiogenesis Inhibitors | 1 | 2018 | 215 | 0.040 |
Why?
| Disease Progression | 1 | 2023 | 2392 | 0.030 |
Why?
| Adipogenesis | 1 | 2017 | 42 | 0.030 |
Why?
| Echocardiography | 1 | 2019 | 555 | 0.030 |
Why?
| Fibrin | 1 | 2017 | 65 | 0.030 |
Why?
| Bioengineering | 1 | 2016 | 13 | 0.030 |
Why?
| Hemodynamics | 2 | 2012 | 1014 | 0.030 |
Why?
| RNA | 1 | 2002 | 810 | 0.030 |
Why?
| Transcriptome | 1 | 2021 | 728 | 0.030 |
Why?
| Treatment Outcome | 1 | 2009 | 9105 | 0.030 |
Why?
| Muscle Development | 2 | 2009 | 98 | 0.030 |
Why?
| GTP Cyclohydrolase | 1 | 2014 | 7 | 0.030 |
Why?
| Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.030 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 369 | 0.030 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2014 | 22 | 0.030 |
Why?
| Guanylate Cyclase | 1 | 2014 | 32 | 0.030 |
Why?
| Estrogen Antagonists | 1 | 2014 | 39 | 0.030 |
Why?
| Cyclic GMP | 1 | 2014 | 78 | 0.030 |
Why?
| Heart Ventricles | 1 | 2019 | 711 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2017 | 817 | 0.030 |
Why?
| Genome, Human | 1 | 2016 | 352 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2018 | 1700 | 0.030 |
Why?
| Monocrotaline | 1 | 2013 | 33 | 0.030 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 193 | 0.030 |
Why?
| Smoking | 1 | 2020 | 1391 | 0.030 |
Why?
| S100 Proteins | 1 | 2013 | 38 | 0.030 |
Why?
| Chronic Disease | 2 | 2009 | 1593 | 0.030 |
Why?
| Societies, Medical | 1 | 2016 | 677 | 0.030 |
Why?
| Glycation End Products, Advanced | 1 | 2013 | 57 | 0.030 |
Why?
| Cyclic N-Oxides | 1 | 2012 | 30 | 0.030 |
Why?
| Infusion Pumps | 1 | 2012 | 31 | 0.030 |
Why?
| Spin Labels | 1 | 2012 | 44 | 0.030 |
Why?
| Arterial Pressure | 1 | 2013 | 99 | 0.030 |
Why?
| Lipid Peroxidation | 1 | 2012 | 139 | 0.020 |
Why?
| Cardiac Output | 1 | 2012 | 143 | 0.020 |
Why?
| Time Factors | 1 | 2002 | 6125 | 0.020 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 525 | 0.020 |
Why?
| Proteins | 1 | 1997 | 912 | 0.020 |
Why?
| Rats, Inbred WKY | 1 | 2011 | 32 | 0.020 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 154 | 0.020 |
Why?
| Naphthalenes | 1 | 2011 | 38 | 0.020 |
Why?
| Free Radical Scavengers | 1 | 2011 | 78 | 0.020 |
Why?
| STAT3 Transcription Factor | 1 | 2013 | 174 | 0.020 |
Why?
| RNA Interference | 1 | 2013 | 437 | 0.020 |
Why?
| Gene Expression | 2 | 2008 | 1422 | 0.020 |
Why?
| Nitrosation | 1 | 2010 | 8 | 0.020 |
Why?
| Risk Factors | 1 | 2023 | 8637 | 0.020 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2011 | 168 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2016 | 1197 | 0.020 |
Why?
| Transcription Factors | 1 | 1997 | 1530 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2009 | 89 | 0.020 |
Why?
| Up-Regulation | 1 | 2013 | 812 | 0.020 |
Why?
| Neoplasms | 1 | 2003 | 2106 | 0.020 |
Why?
| Child | 1 | 2008 | 18366 | 0.020 |
Why?
| Tyrosine | 1 | 2010 | 216 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 400 | 0.020 |
Why?
| Syndecan-3 | 1 | 2009 | 7 | 0.020 |
Why?
| PAX7 Transcription Factor | 1 | 2009 | 9 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2009 | 110 | 0.020 |
Why?
| Capillary Permeability | 1 | 2009 | 135 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2010 | 449 | 0.020 |
Why?
| Stress, Physiological | 1 | 2010 | 378 | 0.020 |
Why?
| Transcriptional Activation | 1 | 2009 | 337 | 0.020 |
Why?
| Nitric Oxide | 1 | 2012 | 827 | 0.020 |
Why?
| Cell Movement | 1 | 2011 | 867 | 0.020 |
Why?
| Perilipin-1 | 1 | 2006 | 16 | 0.020 |
Why?
| Microscopy, Phase-Contrast | 1 | 2006 | 18 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2010 | 927 | 0.020 |
Why?
| Collagenases | 1 | 2006 | 22 | 0.020 |
Why?
| 3T3-L1 Cells | 1 | 2006 | 31 | 0.020 |
Why?
| CD11 Antigens | 1 | 2006 | 31 | 0.020 |
Why?
| Heart Failure | 1 | 2019 | 1952 | 0.020 |
Why?
| Blood Vessels | 1 | 2008 | 180 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2007 | 127 | 0.020 |
Why?
| Oxidative Stress | 1 | 2012 | 1084 | 0.020 |
Why?
| Kidney | 1 | 2012 | 1184 | 0.020 |
Why?
| Antioxidants | 1 | 2009 | 530 | 0.020 |
Why?
| Muscle Proteins | 1 | 2007 | 210 | 0.020 |
Why?
| Green Fluorescent Proteins | 1 | 2006 | 373 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2008 | 1233 | 0.020 |
Why?
| Dietary Fats | 1 | 2006 | 287 | 0.010 |
Why?
| Base Sequence | 1 | 2008 | 2118 | 0.010 |
Why?
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2003 | 5 | 0.010 |
Why?
| Carmustine | 1 | 2003 | 47 | 0.010 |
Why?
| Metabolic Clearance Rate | 1 | 2003 | 104 | 0.010 |
Why?
| Cell Survival | 1 | 2006 | 1022 | 0.010 |
Why?
| Half-Life | 1 | 2003 | 141 | 0.010 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2003 | 68 | 0.010 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2003 | 63 | 0.010 |
Why?
| Carrier Proteins | 1 | 2006 | 696 | 0.010 |
Why?
| Infusions, Intravenous | 1 | 2003 | 372 | 0.010 |
Why?
| Radiation Chimera | 1 | 2001 | 31 | 0.010 |
Why?
| Cell Transplantation | 1 | 2001 | 37 | 0.010 |
Why?
| Myocardial Reperfusion Injury | 1 | 2001 | 91 | 0.010 |
Why?
| Organ Specificity | 1 | 2001 | 270 | 0.010 |
Why?
| United States | 1 | 2016 | 12211 | 0.010 |
Why?
| Myocardial Ischemia | 1 | 2001 | 234 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2006 | 1008 | 0.010 |
Why?
| Graft Survival | 1 | 2001 | 452 | 0.010 |
Why?
| Chick Embryo | 1 | 1999 | 122 | 0.010 |
Why?
| Rabbits | 1 | 1999 | 748 | 0.010 |
Why?
|
|
Majka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|